<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32203916</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-7753</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Stem cell research</Title><ISOAbbreviation>Stem Cell Res</ISOAbbreviation></Journal><ArticleTitle>Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS).</ArticleTitle><Pagination><StartPage>101760</StartPage><MedlinePgn>101760</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scr.2020.101760</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1873-5061(20)30064-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with the loss of upper motor neurons in the cortex and lower motor neurons in the brain stem and spinal cord regressively. The vast majority of ALS cases have no familial history are apparently sporadic (SALS), making the modeling of SALS essential to the development of ALS therapeutics. Therefore, human induced pluripotent stem cell (iPSC) from peripheral blood mononuclear cells of a 64-year-old SALS patient were produced using a virus-free protocol and characterized using standard validate methods. This generated iPSC line could be useful to reveal SALS mechanisms and screen drug development.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China; Human Anatomy Department, Hebei Medical University, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Baofeng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Desheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ruiyun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amponsah</LastName><ForeName>Asiamah Ernest</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yongzhou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; The Second Hospital of Hebei Medical University, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Aijing</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; The Second Hospital of Hebei Medical University, Hebei 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Huixian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei 050017, China; Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei 050017, China; Human Anatomy Department, Hebei Medical University, Hebei 050017, China. Electronic address: huixiancuihmu@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cell Res</MedlineTA><NlmUniqueID>101316957</NlmUniqueID><ISSNLinking>1873-5061</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">differentiation</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cell</Keyword><Keyword MajorTopicYN="N">reprogramming</Keyword><Keyword MajorTopicYN="N">sporadic amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32203916</ArticleId><ArticleId IdType="doi">10.1016/j.scr.2020.101760</ArticleId><ArticleId IdType="pii">S1873-5061(20)30064-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>